Cortagen 20mg

Cortagen is indexed as H-Ala-Glu-Asp-Pro-OH, a short peptide entity with the molecular formula C17H26N4O9 and a computed molecular weight of 430.4 g/mol [1]. This guide covers peptide identity, research literature, COA review, analytical testing, and lot-level documentation. The supplied material is for laboratory research, not consumer use.

• Cortagen is a synthetic tetrapeptide described in published literature as Ala-Glu-Asp-Pro, also abbreviated AEDP [2].
• Researchers evaluate Cortagen research materials through compound identity, amino acid sequence, molecular weight, COA documentation, and batch-specific records.
• Published short peptide literature may discuss gene expression, cellular signal models, and tissue-specific research contexts, but those findings must stay separate from product claims [3].
• COA review should focus on peptide identity, purity, analytical method, lot number, COA date, and document consistency.
• HPLC and LC-MS can support peptide purity and identity review when the methods, data, and batch documents are clearly connected [4], [5].

Fast Answer: What Should Researchers Check Before They Buy Cortagen for Research?

Researchers evaluating where to buy Cortagen for research should start with batch-specific COA documentation, peptide identity, purity testing, lot traceability, RUO labeling, and supplier documentation consistency. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption. Scientific literature may inform research context, but product selection should stay grounded in documentation review.

What Documentation Should Come First for Cortagen Research?

The first documents to review are the product label, batch-specific COA, lot identifier, purity method, identity method, and supplier documentation. For research compounds, the practical question is whether every document identifies the same Cortagen peptide material.

A useful documentation stack includes the compound name, amino acid sequence, molecular formula, molecular weight, COA date, and method notes. PubChem lists H-Ala-Glu-Asp-Pro-OH as C17H26N4O9 with computed molecular weight of 430.4 g/mol, which gives researchers a reference point for identity checks [1].

Why Does RUO Labeling Matter Before Procurement?

RUO labeling sets the page’s intended context before any scientific discussion begins. FDA guidance for in vitro diagnostic products describes RUO labeling as connected to laboratory research-phase materials that are not represented for diagnostic purposes, which is useful as a general example of why research-only labeling must remain clear [6].

What Is Cortagen in Research Literature?

Cortagen appears in the literature as a synthetic tetrapeptide, with the sequence Ala-Glu-Asp-Pro. A PubMed-indexed microarray paper described the synthetic tetrapeptide Cortagen as obtained by directed synthesis based on amino acid analysis of a brain cortex peptide preparation [2].

This makes Cortagen a research peptide with a compact sequence profile.

Cortagen Peptide Identity and Research Classification

Cortagen peptide identity starts with sequence. The amino acid sequence Ala-Glu-Asp-Pro corresponds to the one-letter abbreviation AEDP, and each amino acid is represented as a residue within the peptide chain.

IUPAC defines peptides as amides derived from two or more amino carboxylic acid molecules joined by covalent bonds with formal loss of water [7]. IUPAC also describes an amino-acid residue as what remains of each amino acid after peptide formation [8].

Synthetic Tetrapeptide Classification

A tetrapeptide contains four amino acid residues. Cortagen is a synthetic tetrapeptide because the cited Cortagen literature describes it as Ala-Glu-Asp-Pro and as obtained by directed synthesis [2].

Cortagen Research-Use-Only Scope

Evaluate Cortagen identity, COA consistency, and the relevance of published research before procurement. Research literature does not establish non-research uses for the supplied material.

What Does Research Use Mean for Cortagen?

Research use means the material is intended for laboratory investigation. Procurement review includes compound identity, analytical testing, and lot-specific documentation.

Before procurement, ask what the compound is, how its identity is supported, and which records the laboratory should retain. This guide does not provide personal-use advice.

Compound Identity for a Short Peptide Bioregulator

Cortagen appears in short-peptide and peptide-bioregulator research. Published short regulatory peptide literature discusses gene expression, peptide-DNA interaction hypotheses, and cellular signal models [3].

How Does Molecular Weight Support Peptide Identity Review?

Molecular weight supports identity review by giving procurement teams a value to compare across documentation. PubChem lists H-Ala-Glu-Asp-Pro-OH with computed molecular weight of 430.4 g/mol [1].

This does not prove identity by itself. It becomes more useful when paired with amino acid sequence, molecular formula, LC-MS documentation, and the batch-specific certificate of analysis.

Where Does AEDP Fit in Cortagen Sequence Documentation?

AEDP is the one-letter sequence abbreviation for Ala-Glu-Asp-Pro. In Cortagen documentation, AEDP should match the full sequence, the compound name, and the expected molecular identifiers.

A mismatch across product page, COA, label, or batch documentation should trigger a documentation review. For research buyers, sequence consistency is a practical safeguard.

Scientific Background for Khavinson Peptide Research

Khavinson peptide research has discussed short peptides as small signaling-related molecules in gene expression and protein synthesis literature [3]. Cortagen appears in that broader literature as a synthetic tetrapeptide investigated through gene-expression methods [2].

Published Sources and Short Regulatory Peptides

A systematic review of peptide regulation of gene expression describes short peptides as 2–7 amino acid residues in one discussed classification and reviews DNA, histone, and gene-expression topics [3]. That review also discusses peptide regulation across multiple experimental systems.

This provides context for interpreting short-peptide research. It does not establish product-specific claims for a research material.

What Can Bioregulatory Peptide Context Clarify?

Bioregulatory peptide literature provides context for the gene expression, signaling pathway, and tissue-specific terminology used in Cortagen research.

Gene Expression and Signal Pathway Research Context

The Cortagen microarray study examined gene expression in a preclinical tissue model and reported changes across a limited group of transcripts [2]. Broader short peptide literature also reviews peptide interactions with DNA, histones, and transcription-related mechanisms [3].

What Does Tissue-Specific Gene Expression Mean in Research Models?

Tissue-specific gene expression refers to gene activity measured in a defined biological context. The Cortagen microarray paper examined expression patterns in a specific tissue model rather than making a general product-page claim [2].

That distinction matters.

Why Must Pathway Research Avoid Product Claims?

Pathway research can identify a molecular or cellular context, but it does not automatically support claims for research materials. In broader short peptide literature, terms such as cellular stress, apoptosis, gene expression, and oxidative stress may appear as model-level research concepts [3].

These terms describe the models studied, not established effects of the supplied material.

In Vitro Laboratory Research and Preclinical Research Applications

Cortagen research includes preclinical studies and molecular characterization. Related short-peptide studies have used cell culture models to evaluate differentiation markers and gene-expression-related endpoints [9].

Related short-chain peptide studies use specific experimental model systems; their findings do not establish uses for the supplied material.

What Can In Vitro Models Clarify for Cortagen?

In vitro models can clarify how researchers design controlled observations around cellular markers, peptide signaling concepts, or gene expression endpoints. A cell model can support mechanistic questions while keeping interpretation narrow.

Research Models and Literature Interpretation

A research model is a context, not a guarantee. Different methods, materials, endpoints, and analytical controls can produce different findings.

Procurement teams should assess published research and the supplied lot’s COA separately, because each answers a different question.

How Should Researchers Interpret Cortagen Literature?

Researchers should interpret Cortagen literature by asking what model was used, which endpoint was measured, and how directly the finding relates to compound identity. The Cortagen microarray study used cDNA microarray analysis to examine transcript patterns, making it useful for literature context but not a substitute for batch documentation [2].

A safer reading keeps the evidence level visible.

What Study Design Signals Matter Most?

Useful study design signals include model type, assay method, controls, endpoint definition, sample context, and limitations. In gene-expression literature, microarray or PCR-style approaches should be interpreted as measurement methods rather than product validation methods.

Analytical product documentation is different. HPLC, LC-MS, and COA records help review the supplied research material, while literature studies examine experimental questions.

Comparing Evidence Types

An evidence ladder helps keep interpretation organized.

The table does not rank suppliers or make product claims. It shows which question each evidence type can answer.

Research Literature Versus Product Claims

Published literature and product claims are not the same thing.

Interpreting Study Findings Within Their Limits

Interpret scientific findings according to the source, evidence type, and experimental conditions. The Cortagen microarray result is an observation within a defined research model [2], not a validation of the supplied lot.

Why Does COA Documentation Matter for Cortagen?

COA documentation matters because it links the Cortagen research material to a specific batch. A certificate of analysis should help reviewers connect lot number, compound name, purity method, identity method, and date.

Analytical guidance from ICH Q2(R2) frames validation around whether an analytical procedure is fit for its intended purpose and identifies common analytical purposes such as purity, impurities, identity, and quantitative or qualitative measurement [10]. That principle supports careful review of COA methodology.

What Should a Certificate of Analysis Confirm?

A certificate of analysis should confirm the compound name, batch or lot identifier, purity value, method type, testing date, and identity support. FDA analytical-method guidance discusses documentation of identity, quality, purity, and related analytical data in regulated contexts, which helps explain why documentation quality matters in laboratory review [11].

For Cortagen research procurement, the key is consistency. The COA should match the product label and product-page research material listing.

COA Review for Research Materials Evaluation

COA review should not stop at a single percentage value. The reviewer should check whether the method is named, whether the lot is specific, and whether identity testing is represented clearly.

Peptide reference-standard literature also highlights the role of RP-HPLC in assessing homogeneity, stability, identity, content, and purity for peptide reference standards [12]. That reinforces why method context matters.

Why Does Batch-Specific Documentation Matter for Lab Peptides?

Batch-specific documentation helps lab teams connect the material received to the record being reviewed. Without that connection, a COA may not answer the procurement question.

For lab peptides, the lot number is the bridge. It should appear consistently across COA, label, and supplier documentation.

Purity and Identity Testing for Cortagen Peptide

Purity and identity are related, but they are not identical. Purity review asks about the proportion of the main detected component under a method, while identity review asks whether the material matches the expected Cortagen peptide entity.

ICH Q2(R2) lists purity and identity as common purposes for analytical procedures [10].

HPLC Support for Peptide Purity Review

HPLC can support peptide purity review by separating components and producing chromatographic data. A peer-reviewed methods chapter describes major modes of HPLC used for peptides, including size-exclusion, ion-exchange, reversed-phase, and mixed-mode approaches [4].

In product documentation, HPLC is most useful when the COA gives method context. A purity value without method context is less informative than a purity value tied to a batch and chromatographic record.

LC-MS Support for Identity Verification

LC-MS supports identity review by pairing liquid chromatography with mass spectrometry. A 2021 review proposed LC-MS workflows for characterizing synthetic peptide impurities, and related LC-HRMS literature describes peptide identification, characterization, separation, and quantification of peptide-related impurities [5], [13].

For Cortagen research, LC-MS documentation can help compare observed mass information with expected molecular data. It should be read with the COA, not in isolation.

What Can Analytical Testing Confirm?

Analytical testing can support identity, purity, impurity profiling, and batch documentation when the method is appropriate. It cannot by itself replace all supplier documentation.

Documentation verification workflow:

1. Verify that the compound name, label, COA, and lot number match.
2. Review the batch-specific COA and testing date.
3. Check whether the purity testing method is listed.
4. Confirm whether identity testing is supported by LC-MS or another suitable method.
5. Review chromatogram or mass data when available.
6. Compare molecular formula, molecular weight, and sequence across documents.
7. Record storage and handling documentation in the laboratory file.

Lot Traceability and Batch Documentation Review

Lot traceability helps research buyers connect a specific research material to its supporting documentation. It also helps prevent confusion between a general product description and a batch-specific record.

Analytical-method guidance emphasizes that reference materials or suitably characterized materials with documented identity and purity may be part of validation work [10]. In supplier review, that principle supports attention to documented identity and batch traceability.

What Should Research Buyers Compare Across Supplier Documentation?

Research buyers should compare the product name, lot number, sequence, molecular formula, molecular weight, COA date, analytical methods, and storage documentation. Any mismatch deserves clarification before procurement decisions are finalized.

For Cortagen, the expected sequence is Ala-Glu-Asp-Pro, and the PubChem-indexed formula for H-Ala-Glu-Asp-Pro-OH is C17H26N4O9 [1]. Those identity anchors should align with product documentation.

Why Does Labeling Consistency Matter for Research Procurement?

Labeling consistency matters because it reduces ambiguity. If the product page says Cortagen, the COA says Cortagen peptide, and the label identifies the same lot, the documentation tells a clearer story.

If the naming or lot details diverge, the research buyer should pause. Documentation consistency is a procurement quality signal.

Storage Documentation for Lyophilized Peptide Materials

Storage documentation helps preserve a record of how the research material should be managed in a laboratory inventory system. Many peptide materials are supplied as lyophilized peptide materials, and documentation should state storage conditions clearly.

Peptide stability literature describes physical stability as influenced by intrinsic sequence factors and external conditions [14]. Lyophilization literature also discusses freeze-drying as a common approach for stabilizing protein and peptide-related materials in pharmaceutical development contexts [15].

What Should Lyophilized Peptide Documentation Include?

Lyophilized peptide documentation should include product name, lot number, storage conditions, label status, COA availability, and any handling notes suitable for laboratory inventory records. It should not drift into applied-use guidance.

For Cortagen research materials, storage documentation is part of traceability. It helps the laboratory maintain a consistent record from receipt to archive.

Stability Notes for Laboratory Research Planning

Stability notes should be treated as documentation, not as an outcome claim. They help laboratories plan inventory control and recordkeeping.

Batch documentation and supplier storage notes are more useful than generic statements.

Research Procurement Checklist Before You Buy Cortagen for Research

Before researchers buy Cortagen for research, they should evaluate whether the product page, COA, analytical testing, and label language stay aligned with RUO positioning.

What Should Researchers Verify Before Procurement?

Use this quality and documentation checklist:

• Verify that the compound is labeled for research use only.
• Review the batch-specific certificate of analysis.
• Confirm that purity data are supported by analytical testing.
• Check that the lot number on the COA matches the product documentation.
• Compare compound name, molecular formula, molecular weight, and amino acid sequence across records.
• Assess whether the product page avoids consumer-facing, clinical-use language, and product claims.
• Document storage and handling conditions in a laboratory record.

Research Materials Documentation and Procurement Confidence

Procurement confidence comes from matching records, not from hype. A clear Cortagen research material listing should give qualified researchers enough documentation to review identity, purity, lot traceability, and research-use status.

For peptide research materials, HPLC and LC-MS references can support analytical interpretation when the method and batch are clearly connected [4], [5]. The COA should make that connection visible.

Next-Step Documentation Review for Cortagen Research

The next step is to review documentation before selecting any RUO peptide. A strong review compares product page, label, COA, lot details, analytical testing, and storage notes.

Pure Lab Peptides supplies compounds for laboratory research use only. Products are not intended for human or animal consumption, diagnostic use, therapeutic use, clinical use, veterinary use, or as food, drugs, cosmetics, dietary supplements, or household products. Researchers are responsible for ensuring lawful, appropriate handling and use in accordance with applicable regulations and institutional guidelines.

How Should Teams Review Cortagen Peptide Research Materials?

Teams should review Cortagen peptide research materials as a documentation package. The package should include identity anchors, COA details, analytical testing references, lot traceability, and storage documentation.

What Should Lab Teams Save After They Buy Cortagen for Research?

Lab teams should save the product listing, COA, lot information, storage notes, and any analytical documentation available for the batch. They should also save internal review notes showing that RUO boundaries were checked.

Review the product-page documentation, COA details, and RUO labeling before evaluating this compound for laboratory research.

FAQs

What is Cortagen in a research context?

Cortagen is a research peptide described as a synthetic peptide with the sequence Ala-Glu-Asp-Pro, also represented as AEDP [2]. In sequence terms, alanine, glutamic acid, aspartic acid, and proline define the compound’s identity markers.

What does research use only mean for Cortagen?

Research use only means Cortagen is intended for controlled laboratory research, not consumer or clinical use.

What should researchers consider before they buy Cortagen for research?

Researchers should consider documentation first before they buy Cortagen for research. The key review areas are COA availability, lot traceability, peptide identity, analytical testing, storage documentation, and consistency across the product listing and batch records. A strong procurement review should confirm that the material is presented as a research compound with clear RUO positioning.

Why does a COA matter for Cortagen research materials?

A COA matters for Cortagen research materials because it connects a specific batch to identity, purity, testing method, lot number, and documentation date. It helps technical procurement teams compare the product label with batch-specific documentation. A COA should support research documentation review, but it should not be treated as a substitute for literature interpretation.

How should published literature about Cortagen be interpreted?

Published literature about Cortagen should be interpreted as research context, not product-positioning language. A cited Cortagen study examined gene-expression patterns in a defined research model [2], while broader short peptide literature discusses gene-expression regulation across experimental systems [3]. Those findings should remain tied to research models and should not be converted into product claims.

What analytical methods support Cortagen documentation review?

Analytical methods support Cortagen documentation review by helping evaluate peptide identity and purity. HPLC can support peptide purity review through chromatographic separation, while LC-MS can support identity review through mass-based characterization when paired with suitable batch records [4], [5]. These methods are most useful when linked to the COA and supplier documentation.

---

Researchers Cited in This Guide

The researchers listed below are cited for relevant published work. Their inclusion does not imply that they wrote, reviewed, or endorsed this guide or Pure Lab Peptides products.

Vladimir Khatskelevich Khavinson

Author profile: RUDN Journal of Medicine Profile

Vladimir Khatskelevich Khavinson’s publications address short peptides and peptide bioregulators. They include a PubMed-indexed Cortagen study and broader research on peptide synthesis, molecular interaction models, and gene expression. These publications provide scientific context, not validation of the supplied product.

Selected publications:

• A PubMed-indexed Cortagen research-model study — Neuro Endocrinology Letters, 2004. PMID: [15159690]
• Peptide Regulation of Gene Expression: A Systematic Review — Molecules, 2021. DOI: 10.3390/molecules26227053

Robert S. Hodges

Author profile: CU Anschutz Profile

Robert S. Hodges’s analytical-method publications address peptide HPLC, peptide synthesis, amino acid analysis, mass spectrometry, and characterization of peptides and proteins. His work provides context for assessing analytical methods and distinguishing peptide purity from identity.

Selected publications:

• Analysis of peptides by high-performance liquid chromatography — Methods in Enzymology, 1996. DOI: 10.1016/S0076-6879(96)71003-0
• HPLC Analysis and Purification of Peptides — Methods in Molecular Biology, 2007. DOI: 10.1007/978-1-59745-430-8_1

REFERENCES

1. National Center for Biotechnology Information. H-Ala-Glu-Asp-Pro-OH Compound Summary. PubChem. CID 18439621.
2. Anisimov SV, Khavinson VK, Anisimov VN. Brain cortex tetrapeptide Cortagen in a gene-expression microarray model. Neuro Endocrinology Letters. 2004. PMID: 15159690.
3. Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021. DOI: 10.3390/molecules26227053.
4. Mant CT, Hodges RS. HPLC Analysis and Purification of Peptides. Methods in Molecular Biology. 2007. PMID: 18604941.
5. Lian Z, et al. LC-MS workflow for synthetic peptide characterization. Journal of the American Society for Mass Spectrometry. 2021. PMID: 34110145.
6. U.S. Food and Drug Administration. Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only. FDA Guidance. 2013; page current as of 2018.
7. IUPAC Gold Book. Peptides. International Union of Pure and Applied Chemistry.
8. IUPAC Gold Book. Amino-acid residue. International Union of Pure and Applied Chemistry.
9. Caputi S, Trubiani O, Sinjari B, et al. Short-peptide cell differentiation study. International Journal of Immunopathology and Pharmacology. 2019. DOI: 10.1177/2058738419828613.
10. International Council for Harmonisation. Q2(R2) Validation of Analytical Procedures. ICH Harmonised Guideline. 2023.
11. U.S. Food and Drug Administration. Analytical Procedures and Methods Validation for Drugs and Biologics. FDA Guidance for Industry. 2015.
12. McCarthy D, et al. Reference standards supporting synthetic peptide quality documentation. Pharmaceutics. 2023.
13. Zeng K, et al. LC-HRMS characterization of peptide materials and related impurities. AAPS Journal. 2015.
14. Zapadka KL, Becher FJ, Gomes dos Santos AL, Jackson SE. Factors affecting the physical stability of peptide materials. Interface Focus. 2017.
15. Cheng Y, et al. Practical advice in the development of lyophilized protein product documentation. Pharmaceutical Research. 2024.

---

Research Disclaimer

This material is supplied strictly for in vitro laboratory research and is not for human or veterinary use. Published studies describe specific experimental materials, models, and methods; they do not establish the safety, efficacy, or suitability of this catalog product for non-research use. Review the original publications and the lot-specific analytical documentation independently.